These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21447665)

  • 21. Cross-sectional associations of blood elements, clotting factors, nephropathy, and retinal outcomes in long duration type 1 diabetes.
    Klein BE; Klein R; Howard KP; Lee KE
    Ophthalmic Epidemiol; 2012 Jun; 19(3):120-6. PubMed ID: 22568424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
    Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
    Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinopathy as a predictor of other diabetic complications.
    El-Asrar AM; Al-Rubeaan KA; Al-Amro SA; Moharram OA; Kangave D
    Int Ophthalmol; 2001; 24(1):1-11. PubMed ID: 11998880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J; Nybo M; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural history of diabetic retinopathy in a retrospective cohort of type 1 diabetics].
    Verdaguer J; Zanolli M; Sepúlveda G; García de Los Ríos M; Domínguez A
    Rev Med Chil; 2009 Sep; 137(9):1145-52. PubMed ID: 20011954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.
    Blindbæk SL; Schlosser A; Green A; Holmskov U; Sorensen GL; Grauslund J
    Acta Diabetol; 2017 Apr; 54(4):367-372. PubMed ID: 28039584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
    McCance DR; Dyer DG; Dunn JA; Bailie KE; Thorpe SR; Baynes JW; Lyons TJ
    J Clin Invest; 1993 Jun; 91(6):2470-8. PubMed ID: 8514859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative association between erythrocyte reduced glutathione concentration and diabetic complications.
    Thornalley PJ; McLellan AC; Lo TW; Benn J; Sönksen PH
    Clin Sci (Lond); 1996 Nov; 91(5):575-82. PubMed ID: 8942396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
    Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
    Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines.
    Abhary S; Kasmeridis N; Burdon KP; Kuot A; Whiting MJ; Yew WP; Petrovsky N; Craig JE
    Diabetes Care; 2009 Nov; 32(11):2084-6. PubMed ID: 19675197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
    Busch M; Franke S; Wolf G; Rohde RD; Stein G;
    Nephron Clin Pract; 2008; 108(4):c291-7. PubMed ID: 18434751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.
    Chiarelli F; Pomilio M; Mohn A; Tumini S; Vanelli M; Morgese G; Spagnoli A; Verrotti A
    J Pediatr; 2000 Sep; 137(3):386-92. PubMed ID: 10969265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
    Zhang X; Lai Y; McCance DR; Uchida K; McDonald DM; Gardiner TA; Stitt AW; Curtis TM
    Diabetologia; 2008 Sep; 51(9):1723-30. PubMed ID: 18587559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.